Template:Ramipril: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{CMG}}; {{AE}} {{AZ}}, {{AM}} | ||
{{ | |||
'''''For patient information about Ramipril, click [[Ramipril (patient information)|here]].''''' | |||
===Ramipril=== | |||
[[ | * [[Ramipril tablet]] | ||
[[ | |||
===Ramipril and Hydrochlorothiazide tablet=== | |||
* [[Ramipril and Hydrochlorothiazide tablet]] | |||
==Overview== | |||
'''Ramipril''' tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of [[hypertension]], [[heart failure]], left ventricular dysfunction after [[myocardial infarction]], [[diabetic nephropathy]]. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. [[hypotension]], [[rash]], [[hyperkalemia]], disorder of taste, [[cough]]. | |||
==Category== | |||
Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors. |
Revision as of 20:04, 22 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2], Amr Marawan, M.D. [3]
For patient information about Ramipril, click here.
Ramipril
Ramipril and Hydrochlorothiazide tablet
Overview
Ramipril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.
Category
Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors.